PAM
MDCO

Paradigm Asset Management’s Medicines Co MDCO Stock Holding History

Paradigm Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-8,900
Closed -$338K – 555
2017
Q2 		$338K Sell
8,900
-9,200
-51% -$410K 0.07% 293
2017
Q1 		$885K Buy
18,100
+15,500
+596% +$707K 0.17% 135
2016
Q4 		$88.2K Sell
2,600
-100
-4% -$3.55K 0.02% 431
2016
Q3 		$102K Sell
2,700
-18,100
-87% -$682K 0.02% 418
2016
Q2 		$700K Buy
20,800
+800
+4% +$28.2K 0.12% 147
2016
Q1 		$635K Hold
20,000
– – 0.12% 168
2015
Q4 		$747K Buy
+20,000
New +$756K 0.13% 147
2015
Q3 		– Sell
-33,900
Closed -$970K – 905
2015
Q2 		$970K Hold
33,900
– – 0.11% 207
2015
Q1 		$950K Sell
33,900
-61,500
-64% -$1.73M 0.11% 198
2014
Q4 		$2.64M Hold
95,400
– – 0.34% 105
2014
Q3 		$2.13M Buy
95,400
+41,400
+77% +$1.05M 0.3% 117
2014
Q2 		$1.57M Buy
54,000
+7,100
+15% +$190K 0.21% 147
2014
Q1 		$1.33M Sell
46,900
-3,600
-7% -$119K 0.18% 159
2013
Q4 		$1.95M Sell
50,500
-24,700
-33% -$883K 0.3% 130
2013
Q3 		$2.52M Buy
75,200
+5,600
+8% +$178K 0.41% 86
2013
Q2 		$2.14M Buy
+69,600
New +$2.33M 0.37% 96

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Paradigm Asset Management's MDCO Position: Q3 2017 in Review

Paradigm Asset Management sold out of Medicines Co (MDCO) in Q3 2017, closing a stake of 8,900 shares — an estimated $338K sold.

Paradigm Asset Management first reported a position in MDCO in Q2 2013 and held it in 16 quarters. The position peaked at $2.64M in Q4 2014. 190 funds tracked by Wall St. Rank hold MDCO as of Q3 2017.

  • Paradigm Asset Management reported no remaining Medicines Co position as of Q3 2017 after selling out during the quarter.
  • Paradigm Asset Management sold 8,900 Medicines Co shares in Q3 2017, an estimated $338K.
  • Paradigm Asset Management first reported a position in Medicines Co in Q2 2013 and held it in 16 quarters.
  • Paradigm Asset Management's Medicines Co position peaked at $2.64M in Q4 2014.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q3 2017.

Based on Paradigm Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.